A Comparison of Cell Activation, Exhaustion, and Expression of HIV Coreceptors and Restriction Factors in HIV-1- and HIV-2-Infected Nonprogressors

Human immunodeficiency viruses induce rare attenuated diseases due either to HIV-1 in the exceptional long-term nonprogressors (LTNPs) or to HIV-2 in West Africa. To better understand characteristics of these two disease types we performed a multiplex comparative analysis of cell activation, exhaustion, and expression of coreceptors and restriction factors in CD4 T cells susceptible to harbor those viruses. We analyzed by flow cytometry the expression of HLA-DR, PD1, CCR5, CXCR6, SAMHD1, Blimp-1, and TRIM5α on CD4 T cell subsets from 10 HIV-1+ LTNPs and 14 HIV-2+ (12 nonprogressors and 2 progressors) of the ANRS CO-15 and CO-5 cohorts, respectively, and 12 HIV- healthy donors (HD). The V3 loop of the HIV-1 envelope from 6 HIV-1+ LTNPs was sequenced to determine the CXCR6-binding capacity. Proportions of HLA-DR+ and PD1+ cells were higher in memory CD4 T subsets from HIV-1 LTNPs compared with HIV-2 and HD. Similar findings were observed for CCR5+ cells although limited to central-memory CD4 T cell (TCM) and follicular helper T cell subsets, whereas all major subsets from HIV-1 LTNPs contained less CXCR6+ cells compared with HIV-2. All six V3 loop sequences from HIV-1 LTNPs contained a proline at position 326. Proportions of SAMHD1+ cells were higher in all resting CD4 T subsets from HIV-1 LTNPs compared with the other groups, whereas Blimp-1+ and Trim5α+ cells did not differ. The CD4 T cell subsets from HIV-1 LTNPs differ from those of HIV-2-infected subjects by higher levels of activation, exhaustion, and SAMHD1 expression that can reflect the distinct patterns of host/virus relationships.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:37

Enthalten in:

AIDS research and human retroviruses - 37(2021), 3 vom: 04. März, Seite 214-223

Sprache:

Englisch

Beteiligte Personen:

Diallo, Mariama Sadjo [VerfasserIn]
Samri, Assia [VerfasserIn]
Charpentier, Charlotte [VerfasserIn]
Bertine, Mélanie [VerfasserIn]
Cheynier, Rémi [VerfasserIn]
Thiébaut, Rodolphe [VerfasserIn]
Matheron, Sophie [VerfasserIn]
Collin, Fidéline [VerfasserIn]
Braibant, Martine [VerfasserIn]
Candotti, Daniel [VerfasserIn]
Brun-Vézinet, Françoise [VerfasserIn]
Autran, Brigitte [VerfasserIn]
ANRS CO5 IMMUNOVIR-2 and ANRS CO15 ALT Study Groups [VerfasserIn]
Appay, Victor [Sonstige Person]
Autran, Brigitte [Sonstige Person]
Brun-Vezinet, Françoise [Sonstige Person]
Chaghil, Nathalie [Sonstige Person]
Descamps, Diane [Sonstige Person]
Hosmalin, Anne [Sonstige Person]
Pancino, Gianfranco [Sonstige Person]
Manel, Nicolas [Sonstige Person]
Marchand, Lucie [Sonstige Person]
Pedroza-Martins, Livia [Sonstige Person]
Sàez-Cirion, Asier [Sonstige Person]
Vieillard, Vincent [Sonstige Person]
Agut, Henri [Sonstige Person]
Clauvel, Jean-Pierre [Sonstige Person]
Costagliola, Dominique [Sonstige Person]
Debré, Patrice [Sonstige Person]
Theodorou, Ioannis [Sonstige Person]
Sicard, Didier [Sonstige Person]
Viard, Jean-Paul [Sonstige Person]
Barin, Francis [Sonstige Person]
Vieillard, Vincent [Sonstige Person]
Autran, Brigitte [Sonstige Person]

Links:

Volltext

Themen:

Antiviral Restriction Factors
CD4 T cells
Comparative Study
Coreceptors
EC 2.3.2.27
HIV
Journal Article
Research Support, Non-U.S. Gov't
Restriction factors
TRIM5 protein, human
Tripartite Motif Proteins
Ubiquitin-Protein Ligases

Anmerkungen:

Date Completed 18.08.2021

Date Revised 31.05.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1089/AID.2020.0084

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM316203629